Connect Biopharma Holdings (CNTB) Other Non Operating Income (2024 - 2026)

Connect Biopharma Holdings (CNTB) has reported Other Non Operating Income for 3 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2026.

• Quarterly Other Non Operating Income fell 100.59% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11000.0 (down 97.11% YoY) and the FY2025 annual result came in at $523000.0, down 79.84% from the prior year.
• Other Non Operating Income fell to -$3000.0 in Q1 2026 per CNTB's latest filing, from $60000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for CNTB reached as high as $2.7 million in Q1 2024 and fell as low as -$108000.0 in Q3 2024.
• A 3-year average of $346000.0 and a median of -$3000.0 in 2026 frame the typical range for Other Non Operating Income.
• The largest YoY upside for Other Non Operating Income was 300.0% in 2025 against a maximum downside of 533.33% in 2025.
• Year by year, Other Non Operating Income stood at -$30000.0 in 2024, then jumped by 300.0% to $60000.0 in 2025, then sank by 105.0% to -$3000.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$3000.0, $60000.0, and -$7000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.